GeneticsbioRxivPreprint
The interferon-gamma response pathway is a targetable driver of FSHD muscular dystrophy progression
Beatrice Biferali, Federica Del Prete, Mara Salomè…·Davide Gabellini
This study identifies the IFN-gamma pathway as a therapeutic target for FSHD by showing its role in driving inflammation and disease progression.
DOI 10.64898/2026.10.13.758792